Precision Medicine With Zibotentan in Microvascular Angina
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 225 participants.
Also called NCT04097314
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 225 participants
- Sponsor
- Registry
-
NCT04097314
-
- Other papers using this trial's data
- Exercise treadmill testing for efficacy evaluation in randomized, controlled trials
- Zibotentan in Microvascular Angina: A Randomized, Placebo-Controlled, Crossover Trial
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- United Kingdom
- Registry status
- Completed
Technical summary
Registry record NCT04097314. Randomized; quadruple masking; primary purpose treatment. Start 2019-10-18 (actual); primary completion 2023-06-08 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Precision Medicine With Zibotentan in Microvascular Angina
- Acronym
- PRIZE
- Condition
- Microvascular Angina
- Intervention (Drug)
- Zibotentan
- Intervention (Drug)
- Placebo oral tablet
- Lead sponsor
- NHS Greater Glasgow and Clyde
- Collaborator
- University of Glasgow
- Collaborator
- King's College London
- Collaborator
- University of Oxford
- Collaborator
- Oxford University Hospitals NHS Trust
- Collaborator
- University of Cambridge
- Collaborator
- Papworth Hospital NHS Foundation Trust
- Collaborator
- Blackpool Teaching Hospitals NHS Foundation Trust
- Collaborator
- Royal Free Hospital NHS Foundation Trust
- Collaborator
- AstraZeneca
- Collaborator
- Siemens Healthcare Ltd
Record details
- Record id
cardio:ct-nct04097314- Content hash
9e47af1d031eafef1a567a221ed43a7b029ac8c2acaa481ed937c9988c5b4257